MZTI:NASDAQThe Marzetti Company Analysis
Data as of 2026-06-01 - not real-time
$111.94
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $111.94, well below its 20‑day, 50‑day and 200‑day moving averages, signaling a bearish technical backdrop. Its RSI sits in the low‑30s, suggesting the shares are oversold, while the MACD histogram has turned positive, offering a modest bullish hint. The price is hugging a near‑term support around $110 and faces resistance near $132, with volume trending downward, which could limit upside momentum. Volatility is elevated at over 30% annualized, yet beta is exceptionally low, indicating limited market‑wide price swings. The dividend yield of roughly 3.6% is backed by solid operating cash flow and a payout ratio just above 60%, making the payout appear sustainable. However, the DCF‑derived fair value sits near $97, implying the market is pricing the stock about 15% above intrinsic levels. Recent earnings showed flat revenue and a profit per share that missed consensus, and an ongoing investor‑law firm investigation adds a layer of uncertainty. The acquisition of Bachan’s Japanese Barbecue Sauce brand could inject new growth avenues, but the integration risk remains. Overall, the blend of a defensive consumer staple profile, attractive dividend, and modest profitability is offset by technical weakness, earnings disappointment, and heightened short‑term risk.
Given the extreme‑greed market sentiment, investors should weigh the overvalued price against the sustainable dividend and potential upside from the acquisition, favoring a cautious stance in the near term while keeping an eye on longer‑term fundamentals.
Given the extreme‑greed market sentiment, investors should weigh the overvalued price against the sustainable dividend and potential upside from the acquisition, favoring a cautious stance in the near term while keeping an eye on longer‑term fundamentals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below all major moving averages
- Recent earnings miss and investigation risk
- High short‑term volatility with decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend yield
- Potential growth from Bachan’s acquisition
- Stable cash flow and low leverage
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Defensive consumer‑staple positioning
- Attractive dividend with solid coverage
- Long‑term upside from brand expansion and margin improvement
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin9.06%
P/E Ratio17.5
ROE17.23%
ROA10.97%
Debt/Equity3.56
P/B Ratio2.9
Op. Cash Flow$316.8M
Free Cash Flow$186.7M
Technical Analysis
TrendBearish
RSI32.7
Support$110.31
Resistance$131.74
MA 20$114.95
MA 50$128.35
MA 200$158.33
MACDBullish
VolumeDecreasing
Fear & Greed Index92.89
Valuation
Fair Value$96.71
Target Price$159.40
Upside/Downside42.40%
GradeOvervalued
TypeBlend
Dividend Yield3.57%
Risk Assessment
Beta0.21
Volatility34.54%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.